HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular tumours in infants. Part II: vascular tumours of intermediate malignancy [corrected] and malignant tumours.

Abstract
Malignant cutaneous vascular tumours are very uncommon in children. As in adults, they are aggressive neoplasms with metastatic potential and a high mortality rate. Some nonmalignant vascular tumours may exhibit a locally aggressive behaviour and some of them can be associated with life-threatening systemic complications such as Kasabach-Merritt syndrome. Early diagnosis of these aggressive neoplasms in children is very important in order to start appropriate therapy as soon as possible, as this can have a significant impact on the prognosis of these patients. This review focuses on cutaneous vascular tumours of intermediate dignity (tufted angioma, kaposiform haemangioendothelioma, multifocal lymphangioendotheliomatosis with thrombocytopenia, papillary intralymphatic angioendothelioma, retiform haemangioendothelioma, adult-type haemangioendotheliomas) and malignant vascular tumours in young children (Kaposi sarcoma, angiosarcoma).
AuthorsI Colmenero, P H Hoeger
JournalThe British journal of dermatology (Br J Dermatol) Vol. 171 Issue 3 Pg. 474-84 (Sep 2014) ISSN: 1365-2133 [Electronic] England
PMID24965196 (Publication Type: Journal Article, Review)
Copyright© 2014 British Association of Dermatologists.
Topics
  • Diagnosis, Differential
  • Hemangioendothelioma (pathology)
  • Hemangioma (pathology)
  • Hemangiosarcoma (pathology)
  • Humans
  • Infant
  • Kasabach-Merritt Syndrome (pathology)
  • Lymphangioma (complications, pathology)
  • Neoplasms, Vascular Tissue (pathology)
  • Sarcoma, Kaposi (pathology)
  • Skin Neoplasms (pathology)
  • Thrombocytopenia (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: